Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-07

Clinical Trial Update: L-carnitine Supplementation in Rheumatoid Arthritis Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating L-carnitine supplementation for rheumatoid arthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-carnitine (L-carnitine)

Snippet

Sponsor: German University in Cairo | Conditions: Rheumatoid Arthritis (RA) | Phase 2 | Status: RECRUITING